Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal

S Rijal, S Bhandari, S Koirala, R Singh, B Khanal, L Loutan, JC Dujardin, M Boelaert, F Chappuis

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalTransactions of the Royal Society of Tropical Medicine and Hygiene
    Issue number3
    Pages (from-to)225-229
    Number of pages5
    Publication statusPublished - 2010


    • B780-tropical-medicine
    • Protozoal diseases
    • Visceral
    • Leishmaniasis
    • Kala azar
    • Leishmania
    • Vectors
    • Sandflies
    • Phlebotomus argentipes
    • Control programs
    • Treatment
    • Antimonials
    • Treatment failure
    • Determinants
    • Risk factors
    • Clinical
    • Nepal
    • Asia-South

    Cite this